Javier C Angulo
Overview
Explore the profile of Javier C Angulo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
1138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Morote J, Gomez-Caamano A, Poza de Celis R, Gomez-Veiga F, Ciria J, Calleja J, et al.
Neurourol Urodyn
. 2022 Sep;
41(8):1824-1833.
PMID: 36069170
Aims: To estimate the prevalence of lower urinary tract symptoms (LUTS) in patients with prostate cancer scheduled to receive LHRH analogs, and to assess the effectiveness of LHRH analogs on...
22.
Ullate A, Arance I, Virseda-Chamorro M, Ruiz S, Szczesniewski J, Tellez C, et al.
J Clin Med
. 2022 Aug;
11(16).
PMID: 36013121
(1) Background: Male stress incontinence in patients with previously treated urethral or bladder neck stricture is a therapeutic challenge. The efficacy and safety of the adjustable trans-obturator male system (ATOMS)...
23.
Alcaraz A, Castro-Diaz D, Gacci M, Salonia A, Ficarra V, Carballido-Rodriguez J, et al.
J Clin Med
. 2022 Jul;
11(13).
PMID: 35806900
The objective of this subset analysis was to evaluate and compare the efficacy and tolerability of two combination treatments for men with moderate-to-severe lower urinary tract symptoms associated with benign...
24.
Ruiz-Grana S, Ramos J, Arance I, Angulo J
Cir Esp (Engl Ed)
. 2022 Jun;
100(9):598-600.
PMID: 35700891
No abstract available.
25.
Manini C, Lopez-Fernandez E, Lawrie C, Laruelle A, Angulo J, Lopez J
Curr Urol Rep
. 2022 Apr;
23(6):93-97.
PMID: 35416538
Purpose Of Review: Intratumor heterogeneity (ITH) is an inherent characteristic of most tumors and its detection remains a key task for pathologists. However, the clinical significance of the degree of...
26.
Alcaraz A, Gacci M, Ficarra V, Medina-Polo J, Salonia A, Fernandez-Gomez J, et al.
J Clin Med
. 2022 Feb;
11(4).
PMID: 35207238
We investigated changes in symptoms and quality of life (QoL) in men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) receiving the hexanic extract of ...
27.
Lopez-Fernandez E, Angulo J, Lopez J, Manini C
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35158761
A total of 22 contributions conforms this Special Issue that covers a wide spectrum of contemporary issues in urological cancer, a group of neoplasms with high incidence, prevalence, and mortality...
28.
Dorado J, Angulo J
J Pers Med
. 2022 Jan;
12(1).
PMID: 35055409
(1) Background: The adjustable transobturator male system (ATOMS) device serves to treat post-prostatectomy incontinence, as it enhances residual urinary sphincteric function by dorsal compression of the bulbar urethra. We investigated...
29.
Queissert F, Rourke K, Schonburg S, Giammo A, Gonsior A, Gonzalez-Enguita C, et al.
J Clin Med
. 2022 Jan;
11(1).
PMID: 35011821
(1) Background: This study examined outcomes of second-line ATOMS implantation after failure of the fixed male sling (FMS) AdVance/AdVance XP. (2) Methods: A retrospective multicenter cohort analysis was carried out...
30.
Ruiz S, Virseda-Chamorro M, Salinas J, Queissert F, Arance I, Angulo J
Neurourol Urodyn
. 2021 Dec;
41(2):609-615.
PMID: 34969148
Objective: To assess changes in voiding phase, especially urethral resistance after post-prostatectomy urinary incontinence (PPI) treatment with the Adjustable TransObturator Male System (ATOMS). Material And Methods: A longitudinal prospective study...